Thiotepa is a Intracavitary; Intravenous; Intravesical Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Gland Pharma Limited. The primary component is Thiotepa.
| Product ID | 68083-503_283f8e9e-6f72-4e0b-9459-e7d4430ad0ee |
| NDC | 68083-503 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Thiotepa |
| Generic Name | Thiotepa |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRACAVITARY; INTRAVENOUS; INTRAVESICAL |
| Marketing Start Date | 2022-01-03 |
| Marketing Category | ANDA / |
| Application Number | ANDA214222 |
| Labeler Name | Gland Pharma Limited |
| Substance Name | THIOTEPA |
| Active Ingredient Strength | 100 mg/1 |
| Pharm Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-01-03 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0143-9309 | Thiotepa | Thiotepa |
| 0143-9565 | Thiotepa | Thiotepa |
| 25021-246 | Thiotepa | Thiotepa |
| 43598-171 | Thiotepa | Thiotepa |
| 43598-650 | Thiotepa | Thiotepa |
| 54879-014 | Thiotepa | Thiotepa |
| 65219-029 | Thiotepa | Thiotepa |
| 68083-446 | Thiotepa | Thiotepa |
| 68083-503 | Thiotepa | Thiotepa |
| 69539-123 | Thiotepa | Thiotepa |
| 69539-124 | Thiotepa | Thiotepa |
| 70860-220 | Thiotepa | thiotepa |
| 72205-045 | Thiotepa | Thiotepa |
| 72205-046 | Thiotepa | Thiotepa |
| 53964-001 | TEPADINA | THIOTEPA |
| 53964-002 | TEPADINA | THIOTEPA |
| 70121-1630 | TEPADINA | THIOTEPA |
| 70121-1631 | TEPADINA | THIOTEPA |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() THIOTEPA 73471323 not registered Dead/Abandoned |
AMERICAN CYANAMID COMPANY 1984-03-21 |